Literature DB >> 1704597

Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome.

K Stangl1, K Seitz, A Wirtzfeld, E Alt, H Blömer.   

Abstract

Several studies suggest different effects of atrial (AAI) and ventricular single chamber pacing (VVI) for sick sinus syndrome with respect to the suppression of atrial tachycardias and to the prognosis. With this aspect in mind, we studied 222 patients with sick sinus syndrome, 110 of whom had been supplied with AAI systems, and 112 with VVI systems, in the period from January 1978 to December 1986. The mean observation period was 53 +/- 28 months. The cumulative 5-year survival rate was not significantly different in the two groups. After subgroups with comparable underlying diseases had been differentiated, patients with coronary heart disease showed a significantly higher survival rate (P less than 0.05) under AAI pacing, and the same was shown for patients with no underlying heart disease (P less than 0.02). The incidence of chronic atrial fibrillation was 6% in the AAI group and 19% in the VVI group. Patients with preexisting atrial tachyarrhythmias showed the lowest incidence of chronic atrial fibrillation under AAI pacing. Under VVI pacing this incidence was a function of the basic rate of the pacemaker systems. In conclusion, the pacing mode seems to have a prognostic importance in spite of all methodological difficulties. A suppressive effect of AAI pacing on atrial dysrhythmias can also be assumed.

Entities:  

Mesh:

Year:  1990        PMID: 1704597     DOI: 10.1111/j.1540-8159.1990.tb06946.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  9 in total

Review 1.  Endocavitary treatment of atrial fibrillation.

Authors:  S B Olsson; E I Hertervig; O Kongstad; C Meurling; S Yuan
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 2.  New insights into the mechanisms and management of atrial fibrillation.

Authors:  Paul Khairy; Stanley Nattel
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

3.  Impact of consistent atrial pacing algorithm on premature atrial complexe number and paroxysmal atrial fibrillation recurrences in brady-tachy syndrome: a randomized prospective cross over study.

Authors:  R Ricci; M Santini; A Puglisi; P Azzolini; A Capucci; C Pignalberi; G Boriani; G L Botto; A Spampinato; F Bellocci; A Proclemer; A Grammatico; F de Seta
Journal:  J Interv Card Electrophysiol       Date:  2001-03       Impact factor: 1.900

4.  Arterial thromboembolism in patients with sick sinus syndrome: prediction from pacing mode, atrial fibrillation, and echocardiographic findings.

Authors:  H R Andersen; J C Nielsen; P E Thomsen; L Thuesen; A K Pedersen; P T Mortensen; T Vesterlund
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

5.  Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation.

Authors:  L Padeletti; M C Porciani; A Michelucci; A Colella; P Ticci; S Vena; A Costoli; C Ciapetti; P Pieragnoli; G F Gensini
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

6.  Dual site right atrial pacing in the prevention of symptomatic atrial fibrillation refractory to drug therapy and unrelated to sinus bradycardia.

Authors:  Roberto Boccadamo; Natale Di Belardino; Agostino Mammucari; Valentina Boccadamo
Journal:  J Interv Card Electrophysiol       Date:  2002-06       Impact factor: 1.900

7.  Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study.

Authors:  A V Mattioli; E T Castellani; D Vivoli; F A Sgura; G Mattioli
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

8.  Is dual defibrillator better than conventional DDD pacing in brady-tachy syndrome? Results of the ICARUS Trial (Internal Cardioversion Antitachypacing and Prevention: Resource Utilization Study).

Authors:  Massimo Santini; Renato Ricci; Carlo Pignalberi; Maurizio Russo; Barbara Magris; Nicoletta Grovale; Tiziana De Santo
Journal:  J Interv Card Electrophysiol       Date:  2006-01-18       Impact factor: 1.900

Review 9.  [Pacemaker therapy in patients with atrial fibrillation].

Authors:  A Schuchert; T Meinertz
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.